Oskar Schnappauf PhD , Hongying Wang PhD , Ivona Aksentijevich MD , Daniel L. Kastner MD, PhD , Ronald M. Laxer MD
{"title":"阿什肯纳兹犹太人aicardi - gouti<e:1>综合征患者33年的诊断历程","authors":"Oskar Schnappauf PhD , Hongying Wang PhD , Ivona Aksentijevich MD , Daniel L. Kastner MD, PhD , Ronald M. Laxer MD","doi":"10.1016/j.jacig.2025.100400","DOIUrl":null,"url":null,"abstract":"<div><div>The critical need for awareness and genetic testing of the <em>SAMHD1</em> deletion in Ashkenazi Jewish patients is highlighted owing to its relatively high carrier frequency. Early detection can prevent severe disease complications through targeted therapy.</div></div>","PeriodicalId":75041,"journal":{"name":"The journal of allergy and clinical immunology. Global","volume":"4 2","pages":"Article 100400"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A 33-year diagnostic odyssey in an Ashkenazi Jewish patient with Aicardi-Goutières syndrome\",\"authors\":\"Oskar Schnappauf PhD , Hongying Wang PhD , Ivona Aksentijevich MD , Daniel L. Kastner MD, PhD , Ronald M. Laxer MD\",\"doi\":\"10.1016/j.jacig.2025.100400\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The critical need for awareness and genetic testing of the <em>SAMHD1</em> deletion in Ashkenazi Jewish patients is highlighted owing to its relatively high carrier frequency. Early detection can prevent severe disease complications through targeted therapy.</div></div>\",\"PeriodicalId\":75041,\"journal\":{\"name\":\"The journal of allergy and clinical immunology. Global\",\"volume\":\"4 2\",\"pages\":\"Article 100400\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The journal of allergy and clinical immunology. Global\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772829325000013\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The journal of allergy and clinical immunology. Global","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772829325000013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/3 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
A 33-year diagnostic odyssey in an Ashkenazi Jewish patient with Aicardi-Goutières syndrome
The critical need for awareness and genetic testing of the SAMHD1 deletion in Ashkenazi Jewish patients is highlighted owing to its relatively high carrier frequency. Early detection can prevent severe disease complications through targeted therapy.